Apelinergic System Structure and Function
Authors:
- 1 January 2018
- journal article
- Published by Wiley in Comprehensive Physiology
- Vol. 8 (1) , 407-450
Abstract
Apelin and apela (ELABELA/ELA/Toddler) are two peptide ligands for a class A G‐protein‐coupled receptor named the apelin receptor (AR/APJ/APLNR). Ligand‐AR interactions have been implicated in regulation of the adipoinsular axis, cardiovascular system, and central nervous system alongside pathological processes. Each ligand may be processed into a variety of bioactive isoforms endogenously, with apelin ranging from 13 to 55 amino acids and apela from 11 to 32, typically being cleaved C‐terminal to dibasic proprotein convertase cleavage sites. The C‐terminal region of the respective precursor protein is retained and is responsible for receptor binding and subsequent activation. Interestingly, both apelin and apela exhibit isoform‐dependent variability in potency and efficacy under various physiological and pathological conditions, but most studies focus on a single isoform. Biophysical behavior and structural properties of apelin and apela isoforms show strong correlations with functional studies, with key motifs now well determined for apelin. Unlike its ligands, the AR has been relatively difficult to characterize by biophysical techniques, with most characterization to date being focused on effects of mutagenesis. This situation may improve following a recently reported AR crystal structure, but there are still barriers to overcome in terms of comprehensive biophysical study. In this review, we summarize the three components of the apelinergic system in terms of structure‐function correlation, with a particular focus on isoform‐dependent properties, underlining the potential for regulation of the system through multiple endogenous ligands and isoforms, isoform‐dependent pharmacological properties, and biological membrane‐mediated receptor interaction. © 2018 American Physiological Society. Compr Physiol 8:407‐450, 2018.Keywords
This publication has 311 references indexed in Scilit:
- The Metalloprotease Neprilysin Degrades and Inactivates Apelin PeptidesChemBioChem, 2016
- Stability and degradation patterns of chemically modified analogs of apelin‐13 in plasma and cerebrospinal fluidPeptide Science, 2014
- Elucidation of the Structure–Activity Relationships of Apelin: Influence of Unnatural Amino Acids on Binding, Signaling, and Plasma StabilityChemMedChem, 2011
- Discovery of a Competitive Apelin Receptor (APJ) AntagonistChemMedChem, 2011
- Liquid chromatography/tandem mass spectrometry assay for the absolute quantification of the expected circulating apelin peptides in human plasmaRapid Communications in Mass Spectrometry, 2010
- Exploring the ‘RPRL’ Motif of Apelin‐13 through Molecular Simulation and Biological Evaluation of Cyclic Peptide AnaloguesChemMedChem, 2010
- The hepatic apelin systemHepatology, 2008
- Lipidic Membranes Are Potential “Catalysts” in the Ligand Activity of the Multifunctional Pentapeptide NeokyotorphinChemBioChem, 2005
- Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ ReceptorBiochemical and Biophysical Research Communications, 1998
- Solution structure of human calcitonin in membrane-mimetic environment: The role of the amphipathic helixProteins: Structure, Function, and Bioinformatics, 1998